Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

On the changing role of individuals in different age groups in propagating the Omicron epidemic waves in France

Edward Goldstein
doi: https://doi.org/10.1101/2022.12.22.22283867
Edward Goldstein
1Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: edmugo3{at}gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives In late December 2022, rates of mortality in France (over 2,500 daily deaths) have reached levels not seen since April 2020, with the most pronounced increase in mortality recorded in nursing homes. Epidemics of Omicron and influenza have both contributed to those high mortality levels in late 2022. The roles of different age groups in propagating Omicron epidemics in the whole community require a better characterization, particularly given that in France, vaccination coverage for the 2nd booster for COVID-19 is limited and largely restricted to persons aged over 60y.

Patients and Methods We examined the role of individuals in different age groups in propagating different waves of Omicron epidemics in France between March 1--Dec. 30, 2022 using previously developed methodology based on the relative risk (RR) statistic that measures the change in the group’s proportion among all cases before vs. after the peak of an epidemic wave. Higher value of the RR statistic for a given age group suggests a disproportionate depletion of susceptible individuals in that age group during the epidemic’s ascent (due to increased contact rates and/or susceptibility to infection).

Results For the Spring wave (March 14 - May 15), the highest RR estimate belonged to children aged 10-19y (RR=1.92 (95% CI (1.18,3.12)), followed by adults aged 40-49y (RR=1.45 (1.09,1.93)) and children aged 0-9y (RR=1.31 (0.98,1.74)). For the Summer wave (June 27 – Aug. 21), the highest RR estimate belong to children aged 0-9y (RR=1.61 (1.13,2.30)) followed by children aged 10-19y (RR=1.59 (0.77,3.26)) and adults aged 20-29y (RR=1.42 (0.91,2.23)). For the Autumn wave (Sep. 18 – Nov. 12), the highest RR estimate belonged to children aged 10-19y (RR=1.65 (0.72,3.75)), followed by adults aged 30-39y (RR=1.39 (0.83,2.33)) and 20-29y (RR=1.21 (0.66,2.23)). For the Autumn-Winter Wave (Nov. 23 – Dec. 30), the highest RR estimate belonged to persons aged 30-39y (RR=1.43 (0.79,2.57)), followed by persons aged 80-89y (RR= 1.17 (0.99,1.4)) and persons aged 40-49y (RR= 1.15 (0.73,1.82))).

Discussion/Conclusions Increasing booster vaccination coverage for all adults, as possibly for children should help mitigate future Omicron epidemics. The estimate for the RR statistic in persons aged 80-89y for the Autumn-Winter Omicron wave suggests that additional efforts should be considered for preventing the spread of Omicron infection in elderly persons, including in Long-Term Care facilities.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • edmigo3{at}gmail.com

  • Information on mortality in December, 2022 was added in the analyses/discussion.

Data Availability

This study is based on aggregate, de-identified, publicly available data that can be accessed through refs. 1,20,21

https://www.santepubliquefrance.fr/dossiers/coronavirus-covid-19/coronavirus-chiffres-cles-et-evolution-de-la-covid-19-en-france-et-dans-le-monde

https://www.data.gouv.fr/fr/datasets/donnees-hospitalieres-relatives-a-lepidemie-de-covid-19/

https://www.insee.fr/fr/statistiques/2381472#graphique-Donnes

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted March 02, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
On the changing role of individuals in different age groups in propagating the Omicron epidemic waves in France
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
On the changing role of individuals in different age groups in propagating the Omicron epidemic waves in France
Edward Goldstein
medRxiv 2022.12.22.22283867; doi: https://doi.org/10.1101/2022.12.22.22283867
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
On the changing role of individuals in different age groups in propagating the Omicron epidemic waves in France
Edward Goldstein
medRxiv 2022.12.22.22283867; doi: https://doi.org/10.1101/2022.12.22.22283867

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)